BioSpace News Archive

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Dyno Therapeutics, Inc. (President and CEO: Eric Kelsic, Ph.D., “Dyno”) today announced an option and license agreement was signed on November 23 to develop next-generation adeno-associated virus (AAV) vectors for gene therapy directed to skeletal and cardiac muscle using Dyno’s CapsidMap™ platform.

Titan Medical Inc., a medical technology company focused on the development and commercialization of an innovative single access robotic-assisted surgery system, announced that President and Chief Executive Officer David McNally has stepped down as President and CEO, and resigned from the Board of Directors effective.

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 21 newly-hired employees options to purchase an aggregate of 85,000 shares of Akebia’s common stock on November 30, 2021, as inducements material to each such employee’s entering into employment with Akebia.

VBI Vaccines Inc. today announced that David E. Anderson, Ph.D., VBI’s Chief Scientific Officer, will present updated 12-month and 18-month overall survival (OS) data from the Phase 2a study at the World Vaccine & Immunotherapy Congress at 3:10 PM PT / 6:10 PM ET on December 1, 2021.

Active Life Scientific, Inc. (ALSI) today announced it has received U.S. Food and Drug Administration De Novo clearance for its groundbreaking bone measurement device.

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), today confirmed that the Company’s RT-PCR test for SARS-CoV-2, the virus that causes COVID-19, can successfully detect the recently emerged Omicron variant of the virus.

GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), today announced multiple presentations at the 2021 FAST Global Summit & Gala, highlighting additional supportive data from the initial five patients treated in the Phase 1/2 study of GTX-102, an investigational treatment for Angelman syndrome.

10x Genomics, a life sciences leader focused on mastering biology to advance human health, announced that Chromium X has been named one of The Scientist’s 2021 Top 10 Innovations, an annual list of newly released products that have the potential to generate the biggest impact on scientific research.

Surgical lamps is medical devices used as an integral part during surgeries and invasive medical procedures. Surgical lamps creates illumination that helps in visualization of low contrast objects and small cavities.

With an increase in market competition, laboratory automation has become an indispensable tool for laboratories to keep up with rising work pressure.